OTC Pharmaceuticals - Eastern Europe

  • Eastern Europe
  • The Eastern European OTC Pharmaceuticals market is projected to generate a revenue of US$9.97bn in 2024.
  • This market is expected to experience an annual growth rate of 3.81% (CAGR 2024-2029).
  • Among the various market categories, Other OTC Pharmaceuticals holds the largest share, with a market volume of US$2.60bn in 2024.
  • When compared on a global scale, the in the United States leads in revenue generation, reaching US$41,240.00m in 2024.
  • Taking into account the population figures, the per person revenue in 2024 is estimated to be US$41.93.
  • It is anticipated that by 2024, online sales will contribute 9.01% of the total revenue in the OTC Pharmaceuticals market.
  • In Eastern Europe, the OTC Pharmaceuticals market is experiencing a surge in demand for herbal remedies and natural supplements.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Eastern Europe has been experiencing steady growth in recent years, driven by changing customer preferences and local special circumstances.

Customer preferences:
Customers in Eastern Europe have shown a growing preference for over-the-counter (OTC) medications due to their convenience and accessibility. OTC medications do not require a prescription, allowing customers to easily purchase them from pharmacies or other retail outlets. This has led to an increase in self-medication practices, as customers seek quick and affordable solutions for common health issues.

Trends in the market:
One of the key trends in the OTC Pharmaceuticals market in Eastern Europe is the growing demand for preventive and wellness products. Customers are becoming more proactive in managing their health and are willing to invest in products that can help them maintain their well-being. This trend is driving the growth of OTC products such as vitamins, dietary supplements, and herbal remedies. Another trend in the market is the increasing popularity of generic OTC medications. Generic drugs offer similar therapeutic effects as branded drugs but at a lower cost. This makes them an attractive option for cost-conscious customers in Eastern Europe. The availability of generic OTC medications has expanded in recent years, leading to increased competition in the market.

Local special circumstances:
Eastern Europe has a large aging population, which is contributing to the growth of the OTC Pharmaceuticals market. As people age, they tend to experience more health issues and require medication to manage their conditions. OTC medications provide a convenient and affordable option for elderly individuals who may have multiple health concerns. Furthermore, the healthcare infrastructure in Eastern Europe is still developing in some countries, leading to limited access to healthcare services. As a result, customers often turn to OTC medications as a first-line treatment for common ailments. This reliance on self-medication is driving the demand for OTC Pharmaceuticals in the region.

Underlying macroeconomic factors:
The economic development of Eastern European countries has also played a role in the growth of the OTC Pharmaceuticals market. As disposable incomes rise, customers have more purchasing power to spend on healthcare products, including OTC medications. The increasing middle-class population in Eastern Europe is driving the demand for affordable healthcare solutions, further fueling the growth of the OTC Pharmaceuticals market. In addition, the regulatory environment in Eastern Europe has become more favorable for OTC medications. Governments have implemented policies to promote self-care and encourage the use of OTC products. This has led to increased product availability and a wider range of options for customers in the region. Overall, the OTC Pharmaceuticals market in Eastern Europe is experiencing growth due to changing customer preferences, local special circumstances, and underlying macroeconomic factors. As customers continue to seek convenient and affordable healthcare solutions, the demand for OTC medications is expected to further increase in the region.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)